Show simple item record

dc.creatorBinda, Barbara
dc.creatorPicchi, Giovanna
dc.creatorCarucci, Anna Cecilia
dc.creatorSinatti, Gaia
dc.creatorNorcia, Monica Di
dc.creatorGrimaldi, Alessandro
dc.creatorLancione, Laura
dc.creatorNatili, Andrea
dc.creatorChiappori, Davide
dc.creatorMontali, Filippo
dc.creatorLupi, Diana
dc.creatorMartinez, Viviana
dc.creatorPanarese, Alessandra
dc.creatorD’anselmi, Fabrizio
dc.creatorPisani, Francesco
dc.date.accessioned2020-10-01T16:50:52Z
dc.date.available2020-10-01T16:50:52Z
dc.date.created2020
dc.identifier.issn0041-1345spa
dc.identifier.otherhttps://doi.org/10.1016/j.transproceed.2020.06.026spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/14096
dc.description.abstractBackground. Coronavirus disease 2019 (COVID-19) is a new infectious disease that emerged in China in late 2019 and is now spreading around the world. Social distancing measures were needed to reduce transmission, and lockdown included restricted access to health care facilities. The impact of COVID-19 on transplant recipients is unknown, but considering their immunosuppression status and associated comorbidities, they should be considered a high-risk population. Methods. A kidney transplant center in Central Italy implemented a strategy to maintain follow-up of kidney transplant recipients by phone and e-mail during lockdown. Telephone interviews were used to administer a clinical questionnaire to patients, and e-mail was used to receive the results of diagnostic tests conducted in outpatient settings. Results. From March 17 to April 23, 2020, a total of 143 kidney transplant recipients were contacted. Twenty-eight patients needed in-hospital consultation for problems unrelated to COVID-19, 3 of whom needed hospitalization. Eleven patients were managed at home for mild urinary or respiratory diseases, and 1 was referred to the hematologist. We identified 2 suspected cases of COVID-19 infection, and the patients were referred to hospital care. Immunosuppressive therapy was modulated, and intravenous corticosteroids and potentially effective antiviral therapy were administered with a favorable outcome. Conclusions. In the context of a lockdown, such as that occurring in response to COVID-19, we suggest implementing remote surveillance programs in kidney transplant recipients with the help of any available technology and offering medical consulting and logistic support as needed.spa
dc.format.extent4 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherTransplantation Proceedingsspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectKidney transplantspa
dc.subjectPneumoniaspa
dc.titleFollow-up and management of kidney transplant recipients during the COVID-19 lockdown: The experience of an italian transplant center, including two cases of COVID-19 pneumoniaspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.transproceed.2020.06.026spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record